Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pear Therapeutics, Inc. - Class A Common Stock (NQ:PEAR)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pear Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
35 Stocks Moving In Wednesday's Mid-Day Session
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales... 
Via Benzinga
Where Pear Therapeutics Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Pear Therapeutics (NASDAQ:PEAR) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
From Pear Therapeutics, Inc.
Via Business Wire
Read Why BTIG Sees An Upside OF 55% In Pear Therapeutics
BTIG 
Via Benzinga
Earnings Scheduled For March 28, 2022
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million. 
Via Benzinga
Pear Therapeutics Joins Epic App Orchard to Enable Clinicians to Monitor Prescription Digital Therapeutics
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics, SoftBank Team On Sleep/Wake Disorder Therapeutic For Japanese Market
Pear Therapeutics Inc (NASDAQ: PEAR) has agreed with SoftBank Group Corp (OTC: SFTBY) to develop a Japanese-language digital therapeutic for sleep/wake disorders... 
Via Benzinga
Pear Therapeutics Announces Agreement with SoftBank Corp. to Develop a Digital Therapeutic for Sleep/Wake Disorders for the Japanese Market
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics' Digital Therapeutic For Insomnia Shows Meaningful Reductions In Severity Through 6 Months
Pear Therapeutics Inc (NASDAQ: PEAR) announced data that further underscore the effectiveness of Somryst for chronic insomnia at the World Sleep 2022. 
Via Benzinga
Pear Therapeutics Announces Data from Two Studies Evaluating Prescription Digital Therapeutics (PDTs) for Chronic Insomnia Presented at World Sleep Congress 2022
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on March 28, 2022 at 4:30 p.m. Eastern Time
From Pear Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers TherapeuticsMD (NASDAQ:TXMD) stock moved upwards by 38.1% to $0.29 during Monday's regular session. As of 12:30 EST, TherapeuticsMD's stock is trading at a... 
Via Benzinga
Pear Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy Inclusive of All of Its Commercial Products
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Participate in Citi’s 2022 Virtual Healthcare Conference
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics Announces Availability of reSET® and reSET-O® in Spanish
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics Announces State of Michigan to Fund Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Participate in 9th Annual BTIG MedTech, Digital Health, Life Science & Diagnostics Conference
From Pear Therapeutics, Inc.
Via Business Wire
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2022
Upgrades 
Via Benzinga
Oklahoma Health Care Authority and Pear Therapeutics Enter into Value-Based Agreement for reSET® and reSET-O®
From Pear Therapeutics, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
Upgrades For W.P. Carey Inc (NYSE:WPC), B... 
Via Benzinga
Pear Therapeutics Announces Operational Performance Metrics for Full Year 2021 and Reaffirms Financial and Operational Performance Metrics for Full Year 2022
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Further Support Point32Health Members in Recovery from Substance Use Disorders
From Pear Therapeutics, Inc.
Via Business Wire
45 Biggest Movers From Yesterday
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... 
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women... 
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 150 Points; Applied Therapeutics Shares Slide
Toward the end of trading Monday, the Dow traded up 0.43% to 36,496.18 while the NASDAQ rose 0.93% to 15,790.97. The S&P also rose, gaining 0.43% to 4,786.68. The U.S. has the... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa... 
Via Benzinga
Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher
Midway through trading Monday, the Dow traded up 0.18% to 36,402.21 while the NASDAQ rose 0.75% to 15,762.21. The S&P also rose, gaining 0.23% to 4,776.99. The U.S. has the... 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.